Journal article
De Novo Variants in the F-Box Protein FBXO11 in 20 Individuals with a Variable Neurodevelopmental Disorder
A Gregor, LG Sadleir, R Asadollahi, S Azzarello-Burri, A Battaglia, LB Ousager, P Boonsawat, AL Bruel, R Buchert, E Calpena, B Cogné, B Dallapiccola, F Distelmaier, F Elmslie, L Faivre, TB Haack, V Harrison, A Henderson, D Hunt, B Isidor Show all
American Journal of Human Genetics | CELL PRESS | Published : 2018
Abstract
Next-generation sequencing combined with international data sharing has enormously facilitated identification of new disease-associated genes and mutations. This is particularly true for genetically extremely heterogeneous entities such as neurodevelopmental disorders (NDDs). Through exome sequencing and world-wide collaborations, we identified and assembled 20 individuals with de novo variants in FBXO11. They present with mild to severe developmental delay associated with a range of features including short (4/20) or tall (2/20) stature, obesity (5/20), microcephaly (4/19) or macrocephaly (2/19), behavioral problems (17/20), seizures (5/20), cleft lip or palate or bifid uvula (3/20), and mi..
View full abstractGrants
Awarded by Australian Research Council
Funding Acknowledgements
We thank all affected individuals and their families for participating in this study. We thank Laila Distel for excellent technical assistance. We thank Christian T. Thiel for the in-house NGS tool and Arif Ekici and Steffen Uebe from the NGS facility in the Institute of Human Genetics, Erlangen. This study makes use of data generated by the DECIPHER community (for additional information see Supplemental Acknowledgements). Studies regarding individuals 18 and 11 were supported by grant PI14/00350 (Instituto de Salud Carlos III - Accion Estrategica en Salud 2013-2016; FEDER - Fondo Europeo de Desarrollo Regional) and by PARI 2012 from Regional Council of Burgundy / Dijon University Hospital, respectively. Exome sequencing for individual 7 was performed at the University of Washington Center for Mendelian Genomics (UW-CMG) and was funded by the NHRGI and the NHLBI (grant HG006493). L.G.S. is supported by grants from the Health Research Council and Cure Kids New Zealand. A. Rauch was supported by the ERA-NET grant "Euromicro" (SNF 31ER30_154238). A. Reis was supported by the German Ministry of Education and Research (01GS08160) and the Interdisciplinary Center for Clinical Research (IZKF) Erlangen (E16). F.D. was supported by a grant of the German Research Foundation (DFG) (DI 1731/2-1). T.B.H. is supported by the German Federal Ministry of Education and Research (BMBF) through the Juniorverbund in der Systemmedizin "mitOmics" (01ZX1405C). N. Matsumoto is supported by grants from AMED (JP18ek0109280, JP18dm0107090, and JP18ek0109301). C.Z. is supported by grants from the DFG (ZW184/1-2, ZW184/3-1, and GRK2162) and by the IZKF Erlangen (E26).